Editorial: The heterogeneity of epithelial ovarian cancer. Getting it right David M. Gershenson

Editorial
The heterogeneity of epithelial ovarian cancer
Getting it right

David M. Gershenson, MD *
Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
email: David M. Gershenson (DGERSHEN@mdanderson.org)

Abstract
Epithelial ovarian cancer is heterogeneous and comprises 4 major rare subtypes - mucinous, clear cell, low-grade serous, and endometrioid - all distinct from the more common high-grade serous carcinoma. Women with uncommon histotypes should be triaged to separate clinical trials.

Drug interactions with antiretrovirals and warfarin; Expert Opinion on Drug Safety

Pathways to the diagnosis of ovarian cancer in the UK: a cohort study in primary care BJOG

PD 0332991 in Treating Patients With Refractory Solid Tumors - Full Text View - ClinicalTrials.gov

PD 0332991 in Treating Patients With Refractory Solid Tumors - Full Text View - ClinicalTrials.gov

Communicate (animated film on you, your health, and the internet) - Denise Silber's eHealth

Search of: ovarian cancer | Open Studies | Adult - Results by Topic - ClinicalTrials.gov

Search results for Dietary Supplement - ovarian cancer:

Acidophilus 1 study
Arginine 1 study
Calciferol 4 studies
Cholecalciferol 3 studies
Citrate 13 studies
Folate 7 studies
Folic Acid 7 studies
Folinic Acid 8 studies
Orange 1 study
Tea 1 study
Tyrosine 1 study
Vitamin B9 7 studies
Vitamin D3 3 studies

Search of: ovarian cancer | Open Studies | Adult - Results by Topic - ClinicalTrials.gov

Search of: ovarian cancer | Open Studies | Adult - Results by Topic - ClinicalTrials.gov

Cancer patients 'must know rights' UK/Macmillan Cancer Centre

"Macmillan Cancer Support said that workers don't realise the Disability Discrimination Act (DDA) also protects cancer patients. A survey for the charity found more than half (53 per cent) of the 1,000 people questioned did not realise the act also applied to cancer patients."

A Physician's Perspective on Health 2.0 and Participatory Medicine

32 minute video

media article: The inherited malignancy of breast cancer (and ovarian cancer)

Note: good article, albeit complicated subject matter - excerpts of important information:

Soy product and isoflavone intake and breast cancer risk defined by hormone receptor status. 2009; Cancer Science

"he association between soy food consumption and breast cancer risk has been inconsistent. A hospital-based case–control study was conducted to assess the relationship between soy food intake and breast cancer risk according to the estrogen receptor (ER) and/or progesterone receptor (PR) status of breast cancer in Chinese women .....The protective effects of soy did not seem to differ by ER and PR breast cancer status."

(abstract) Aberrant DNA methylation in contrast with mutations. 2009; Cancer Science

Note: technical/short abstract

OCATS - Ovarian Cancer (Canada)